Reply  by Cummings, Jennifer E. et al.
SCMR are committed and capable of moving forward together in
productive ways on behalf of cardiovascular specialists to enable the
training and clinical opportunities in CMR to flourish.
Moving forward from this survey, the purpose of which was, in
part, to identify the current state-training opportunities for the
modalities, there is a need to translate its results into action. Dr.
Christian identifies the current shortage of training opportunities,
which we are hopeful is primarily a near-term problem that will
ease as training opportunities rapidly expand into new centers with
sufficient expertise and personnel experienced in advanced imaging
modalities. Creative approaches to funding such opportunities are
critical to their development and success.
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Preservation of the Anterior Fat Pad
and Incidence of Postoperative Atrial
Fibrillation Following Coronary Surgery
We read with interest the recent contribution by Cummings et al.
(1) about the reduced incidence of postoperative atrial fibrillation
(AF) in patients with preservation of the anterior fat pad (FP). The
investigators performed an elegant evaluation of parasympathetic
tone influence in a group of 55 patients undergoing myocardial
revascularization on-pump and randomized either to group A (26
patients with anterior FP preservation) or group B (29 patients
with dissection of the anterior FP). The incidence of postoperative
AF was significantly less in group A (group A  7% vs. group
B  37%; p  0.01); the researchers conclude that anterior FP
preservation decreases the incidence of postoperative AF (1).
Besides the limitation of the study represented by the small
sample size of patients randomized either to anterior FP preser-
vation or removal, the study method holds additional limitations to
the ones depicted by the investigators. First, despite patient use of
class I or III antiarrhythmic medications being considered as an
exclusion criteria, patients taking class II and IV antiarrhythmic
drugs were not excluded from the study. In particular, patients
with preoperative oral intake of beta-blockers did not withdraw
their medications, as depicted in Table 1. It is questionable
whether this fact may bias the results of the study as previous
reports demonstrated that the perioperative withdrawal of beta-
blockers may hamper efforts to reduce the incidence of postoper-
ative AF. In particular, Salamon et al. (2) demonstrated that
off-pump surgery alone was not effective in reducing postoperative
AF without concomitant beta-blocker administration. Addition-
ally, the use of different techniques for myocardial protection (i.e.,
cold blood oxygenated or crystalloid cardioplegia) may add another
bias to the entire study; conversely, avoidance of cardiopulmonary
bypass at all would have reduced a well-known risk of developing
AF (3).
Finally, Cummings et al. (1) report a prevalence of diabetes in
a relatively high percentage of patients (about 35% in both groups
of the study population). Because autonomic neuropathy with
partial denervation commonly occurs in diabetic patients (4), the
real effectiveness of anterior FP preservation in this population may
be questionable, and this fact would therefore raise additional
concerns about the final validation of the study.
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REPLY
We thank Dr. Bisleri and colleagues for their thoughtful review of
our study, and we appreciate the opportunity to respond.
Although the sample size was small, our investigation was
powered and sample size calculated using a moderate effect size
prior to the initiation of the study; thus, this study had adequate
power.
Their first concern addresses the use of perioperative beta-
blockers in the entire population. The use of beta-blockers in
coronary artery disease, especially following coronary artery bypass
graft surgery (CABG), remains the standard of care (1,2). With-
drawal or withholding of these medications was therefore not
considered.
Additionally, Dr. Bisleri and colleagues expressed concern in
regard to bias in the significant amount of beta-blocker use (90%
compliance in both groups), selection of cardioplegia, and number
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of diabetic patients enrolled. Ours was a prospective randomized
study. By randomizing the patients prior to their procedure, the
possibility of bias was negated. As noted in our Table 1, no
significant differences existed between groups in any patient
characteristic (including cardioplegia type, diabetes, and beta-
blocker use) (3).
Both groups demonstrated an equal number of diabetics, use of
beta-blockers, and cold or warm blood cardioplegia. Therefore, the
differences between the groups seen at the conclusion of the study
cannot be attributed to any of these factors. As Dr. Bisleri and
colleagues state, there was an equal number of diabetics in both
groups (35% vs. 31%; p  NS) (3). Although this number of
diabetic patients is higher than expected for the general popula-
tion, we were evaluating bypass patients in whom a higher
incidence of diabetes is expected. As there were no significant
differences in the patient characteristics, the effect on atrial
fibrillation seen at the conclusion of the study is separate and
significant.
Finally, the concern that “off-pump” bypass surgery decreases a
“well-known” risk of atrial fibrillation is relevant to our study.
During “off-pump” bypass, there is no cross-clamp applied, and
minimal if any anterior fat pad dissection occurs. We agree that
this may be one of the factors reducing the risk of atrial fibrillation
using this approach.
In summary, the prospective randomized design of our study
should address the concerns of Dr. Bisleri and colleagues. We
agree that this study generates many questions regarding the
mechanism of postoperative atrial fibrillation, and we look forward
to future studies. The reality is that the sample size was small and
although the patients were randomized, dogmatic conclusions are
not warranted, at least not yet.
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Cardiac Complications of Vaccines
We read with interest the recent study by Eckart et al. (1) entitled
“Incidence and Follow-Up of Inflammatory Cardiac Complica-
tions After Smallpox Vaccination.” Although smallpox is the most
common vaccine that is associated with myocarditis, other vaccines
have also been linked with myocarditis, such as diphtheria–
tetanus–polio vaccine, tetanus vaccine alone, cholera, typhoid–
cholera, and variola vaccines (2–6). In order to assess any relation-
ship between smallpox vaccination and myocarditis more
accurately, it would be essential to know what other vaccines were
administered to the military personnel in the study. Moreover, was
there any relationship between specific lot numbers and myocarditis?
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REPLY
We appreciate the comments of Dr. Kula and colleagues regarding
our publication on vaccinia-associated myocarditis (1). We agree
with the need to consider the possible contributions of other
vaccinations to myocarditis, and we recognize the potential for
confounding. Our group recently published data revealing no
statistically significant association of development of vaccinia-
associated myocarditis in those with concomitant administration of
other vaccines (2). Other vaccines in addition to vaccinia in cases
of myocarditis may have included anthrax, typhoid, hepatitis A,
hepatitis B, influenza, meningococcal, MMR (measles, mumps,
rubella), poliovirus, and yellow fever vaccines. No association was
seen between specific lot numbers and development of myocarditis.
We note that all the available references cited by Kula and
colleagues were isolated case reports relating to other vaccines
(3–6). Although they raise interesting questions, the reported
observations are less persuasive than the extended case series we
have reported (1,2). Recognizing that our experience is not within
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